# FDA recall D-0159-2023

> **Ascend Laboratories, LLC** · Class II · drug recall initiated 2022-12-28.

## Product

Rasagiline Mesylate Tablets 1 mg; 30 tablets in HDPE bottle; Rx only; NDC 67877-260-30; Manufactured by Alkem Laboratories Ltd., India; Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054

## Reason for recall

Presence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.

## Distribution

Customers in 19 states: CA, FL, GA, IL, KY, LA, MI, MN, MS, NC, NJ, NY, OH, PA, RI, TN, TX, WA, WI; Puerto Rico

## Key facts

- **Recall number:** D-0159-2023
- **Recalling firm:** Ascend Laboratories, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-12-28
- **Report date:** 2023-01-25
- **Termination date:** 2024-08-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Parsippany, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0159-2023

## Citation

> AI Analytics. FDA recall D-0159-2023. Retrieved 2026-07-19 from https://api.ai-analytics.org/recall/D-0159-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*